{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T21:23:55Z","timestamp":1787261035932,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpagonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric and Adolescent Gynecology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jpag.2026.06.017","type":"journal-article","created":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T05:38:21Z","timestamp":1782625101000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["GLP-1 Receptor Agonists in Adolescents: Emerging Endocrine, Reproductive, and Psychosocial Concerns"],"prefix":"10.1016","author":[{"given":"Muhammad Ali","family":"Haider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haseeba","family":"Javed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpag.2026.06.017_bib0001","article-title":"Efficacy of liraglutide on metabolic and reproductive outcomes in women with polycystic ovary syndrome: a systematic review and meta-analysis","author":"Lu","year":"2026","journal-title":"Diabetes Obes Metab."},{"issue":"1","key":"10.1016\/j.jpag.2026.06.017_bib0002","doi-asserted-by":"crossref","DOI":"10.1080\/09513590.2025.2553052","article-title":"Meta-analysis of the effects of semaglutide on body mass index (BMI) and blood lipid levels in polycystic ovary syndrome patients","volume":"41","author":"Chen","year":"2025","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.jpag.2026.06.017_bib0003","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12958-025-01447-3","article-title":"Combined metformin and semaglutide therapy in PCOS","volume":"23","author":"Chen","year":"2025","journal-title":"Reprod Biol Endocrinol"},{"issue":"3","key":"10.1016\/j.jpag.2026.06.017_bib0004","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/ejendo\/lvag033","article-title":"GLP-1 receptor agonist treatment in women with polycystic ovary syndrome-a systematic review and meta-analysis","volume":"194","author":"Forslund","year":"2026","journal-title":"Eur J Endocrinol."},{"key":"10.1016\/j.jpag.2026.06.017_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2026.03.1002","article-title":"Glucagon-like peptide-1 receptor agonists in psychiatry: a pharmacoepidemiological scoping review","author":"Volkow","year":"2026","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jpag.2026.06.017_bib0006","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.25079","article-title":"Adolescent body mass index and osteoporosis risk","volume":"8","author":"Simchoni","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jpag.2026.06.017_bib0007","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"108","author":"Teede","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpag.2026.06.017_bib0008","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1056\/NEJMoa2208601","article-title":"Once-weekly semaglutide in adolescents with obesity","volume":"387","author":"Weghuber","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpag.2026.06.017_bib0009","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1916038","article-title":"Liraglutide for adolescents with obesity","volume":"382","author":"Kelly","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.jpag.2026.06.017_bib0010","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/jamapediatrics.2025.3243","article-title":"Efficacy and safety of GLP-1 receptor agonists in children and adolescents","volume":"179","author":"Kotecha","year":"2025","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jpag.2026.06.017_bib0011","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1186\/s12889-018-6206-y","article-title":"Dieting and bone mineral accrual in adolescent girls","volume":"18","author":"Hohman","year":"2018","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jpag.2026.06.017_bib0012","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1196\/annals.1429.002","article-title":"Skeletal effects of eating disorders in adolescence","volume":"1135","author":"Misra","year":"2008","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.jpag.2026.06.017_bib0013","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s12020-025-04253-4","article-title":"Glucagon-like peptide-1 receptor agonists (GLP-1RAs) for the treatment of type 2 diabetes mellitus: friends or foes to bone health? A narrative review of clinical studies","volume":"89","author":"Al Refaie","year":"2025","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.jpag.2026.06.017_bib0014","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00592-025-02468-5","article-title":"Effect of GLP-1 receptor agonists on bone mineral density, bone metabolism markers, and fracture risk in type 2 diabetes: a systematic review and meta-analysis","volume":"62","author":"Tan","year":"2025","journal-title":"Acta Diabetologica"},{"key":"10.1016\/j.jpag.2026.06.017_bib0015","article-title":"Exercise and GLP-1 therapy effects on bone health","volume":"7","author":"Jensen","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"24","key":"10.1016\/j.jpag.2026.06.017_bib0016","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1001\/jama.2025.20951","article-title":"Gestational weight gain and pregnancy outcomes after GLP-1 receptor agonist discontinuation","volume":"334","author":"Maya","year":"2025","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.jpag.2026.06.017_bib0017","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.3390\/jcm15093204","article-title":"GLP-1 receptor agonists, fertility restoration, and reproductive safety in women of reproductive age: a narrative review","volume":"15","author":"Abedi","year":"2026","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.jpag.2026.06.017_bib0018","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ajog.2024.08.024","article-title":"Glucagon-like peptide-1 receptor agonist use in pregnancy: a review","volume":"232","author":"Drummond","year":"2025","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.jpag.2026.06.017_bib0019","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1001\/jamapsychiatry.2025.0679","article-title":"Glucagon-like peptide 1 receptor agonists and mental health: a systematic review and meta-analysis","volume":"82","author":"Pierret","year":"2025","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpag.2026.06.017_bib0020","article-title":"Psychiatric adverse events associated with GLP-1 receptor agonists: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database","volume":"15","author":"Chen","year":"2024","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jpag.2026.06.017_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.bodyim.2026.102095","article-title":"Body image in the age of GLP-1s: emerging questions for research and practice","volume":"57","author":"Craddock","year":"2026","journal-title":"Body Image"},{"issue":"1","key":"10.1016\/j.jpag.2026.06.017_bib0022","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ajcnut.2025.04.023","article-title":"Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory","volume":"122","author":"Mozaffarian","year":"2025","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"10.1016\/j.jpag.2026.06.017_bib0023","doi-asserted-by":"crossref","DOI":"10.1111\/obr.70049","article-title":"GLP-1 receptor agonist medications for obesity and type 2 diabetes treatment: a rapid review of changes in eating behaviors and eating disorder risk","volume":"27","author":"Jebeile","year":"2026","journal-title":"Obes Rev"},{"key":"10.1016\/j.jpag.2026.06.017_bib0024","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jpsychires.2026.03.008","article-title":"The dual role of GLP-1 receptor agonists in weight management and eating disorders: potential benefits and risks","volume":"197","author":"Leziak","year":"2026","journal-title":"J Psychiatr Res"},{"issue":"1","key":"10.1016\/j.jpag.2026.06.017_bib0025","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.psc.2025.08.013","article-title":"Use (and potential for abuse) of glucagon-like peptide-1 medications among individuals with eating disorders","volume":"49","author":"Schaefer","year":"2026","journal-title":"Psychiatr Clin North Am"},{"issue":"1","key":"10.1016\/j.jpag.2026.06.017_bib0026","first-page":"91","article-title":"GLP-1 receptor agonists for obesity in adolescents","volume":"113","author":"Schoenherr","year":"2026","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jpag.2026.06.017_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103363","article-title":"The expanding role of GLP-1 receptor agonists","volume":"86","author":"Moiz","year":"2025","journal-title":"EClinicalMedicine"}],"container-title":["Journal of Pediatric and Adolescent Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083318826004493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083318826004493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T20:27:42Z","timestamp":1787257662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083318826004493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":27,"alternative-id":["S1083318826004493"],"URL":"https:\/\/doi.org\/10.1016\/j.jpag.2026.06.017","relation":{},"ISSN":["1083-3188"],"issn-type":[{"value":"1083-3188","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GLP-1 Receptor Agonists in Adolescents: Emerging Endocrine, Reproductive, and Psychosocial Concerns","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric and Adolescent Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpag.2026.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 North American Society for Pediatric and Adolescent Gynecology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}